An expert panel has recommended an expanded treatment envelope for the EPA drug Vascepa. An expert says the move won’t affect the supplement market directly but does add to recent official recognition of the health benefits of omega-3s.
Natures Crops, the exclusive producers behind plant-based Ahiflower oil, has entered into a global supply agreement with nutraceutical products brand Braini.
Norwegian marine oil innovator Epax will invest $35 million over the next two years in upgrading its facilities to maximize sustainability and meet consumer demand.
Eating mussels three times per week may help bring about significant health benefits such as reducing the risk of cardiac arrest thanks to their omega-3 fatty acid properties, according to researchers from the University of Stirling.
Norwegian firm Epax is to invest €32m over the next two years in upgrading its facilities and capacity in response to consumer demand for high-potency omega-3 oils.
People taking omega-3 supplements are at lower risks of heart attack and other cardiovascular disease (CVD) events but gain no benefit for stroke, according to a new meta-analysis.
CVS has agreed to pay refunds on a brand of memory supplements, according to the Center for Science in the Public Interest, which had sued the company on behalf of consumers.
Trade body Natural Health Products New Zealand has called for the removal of a research paper which claimed that six out of 10 of the country’s best-selling fish oil products contained less omega-3 fatty acids than what was stated.
Polyunsaturated fatty acids (PUFAs), and in particular eicosapentaenoic acid (EPA), has shown the strongest evidence for improving cognitive disorders, such as depression, according to a meta-review.
Omega-3 supplements should not be encouraged to help tackle diabetes, University of East Anglia researchers have argued following a systematic review that found no benefit of the supplement.
